Several studies indicate that overexpression of these genes is instrumental in driving the development of MLL-r leukemia and that their suppression is sufficient to compromise MLL-r cancer cell survival [15, 16, 20, 25, 26]. The gene discussed is KMT2A; the disease is cancer.